![Enrique Codina Gibert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Enrique Codina Gibert
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Pharmacelera SL
![]() Pharmacelera SL Information Technology ServicesTechnology Services Pharmacelera SL engages in providing hardware and software solution services for pharm screen and pharmQSAR. Its products include pharmScreen, phramQSAP and phramaBox. The company was founded by Enric Herrero Abellanas and Enric Gibert Codina and is headquartered in Barcelona, Spain.
2
| Holding Company | Information Technology Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Enrique Codina Gibert via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Macrophage Pharma Ltd.
![]() Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Chief Executive Officer | |
SANOFI | Pharmaceuticals: Major | Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Proteome Therapeutics, Inc.
![]() Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Biotechnology | Chief Executive Officer | |
GLENMARK PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
General Inception
![]() General Inception Investment ManagersFinance General Inception Management LLC (General Inception Management) is a venture capital firm founded in 2020 by Vikram Chaudhery, Paul A. Conley and Jim Buzzitta. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 4 |
Duitsland | 2 |
Verenigd Koninkrijk | 2 |
Frankrijk | 2 |
India | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Finance | 2 |
Operationeel
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sterkste connecties
Insiders | |
---|---|
Venkat Reddy | 9 |
Abellanas Herrero | 1 |
- Beurs
- Insiders
- Enrique Codina Gibert
- Bedrijfsconnecties